Conmed (CNMD) Tops Q2 EPS by 88c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
CONMED Corporation Announces Second Quarter 2020 Financial Results
July 29, 2020 4:05 PM EDTUTICA, N.Y.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2020.
Second Quarter 2020 Highlights
Sales of $157.8 million decreased 33.8% year over year as reported and 32.6% in constant currency. Domestic revenue decreased 32.2% year over year. International revenue decreased 35.6% as reported and 33.0% in constant currency. Diluted net loss per share (GAAP) was $0.96, compared to diluted net earnings per share of $0.19 in the second quarter of 2019. Adjusted diluted net loss per share(1) was $0.07 versus... More


